Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC0482 Adx61623
Novel Nonsteroidal Negative Allosteric Modulator of Follicle-Stimulating Hormone Receptor (FSHR)
More description
DCC0481 Adtl-ei1712
The first selective dual-target inhibitor of ERK1 and ERK5
More description
DCC0480 Adt-061
Novel PDE10 inhibitor, reducing oncogenic β-catenin, suppressing TCF/LEF transcription
More description
DCC0479 Ads-j1
Inhibitor of semen-derived amyloid fibril formation, blocking fibril-mediated enhancement of HIV-1 infection
More description
DCC0478 Ads-103317
Novel Inhibitor of EGF-EGFR Interactions
More description
DCC0477 Adrenaline Sulfate
Nonselective agonist of all adrenergic receptors, including the major subtypes alpha1, alpha2, ß1, ß2, and ß3
More description
DCC0476 Adr-925
Active iron-chelating metabolite of dexrazoxane
More description
DCC0475 Adp-hpd
Poly(ADP-Ribose) Glycohydrolase (PARG) inhibitor
More description
DCC0474 Adp-2341
Novel soluble analog of FiVe1
More description
DCC0473 Adjuvant Nada
Novel antibiotic adjuvant, exhibiting as high as 4096-fold potentiation of multiple classes of antibiotics toward critical Gram-negative superbugs
More description
DCC0472 Adjuvant
Novel antibiotic adjuvant, exhibiting as high as 4096-fold potentiation of multiple classes of antibiotics toward critical Gram-negative superbugs
More description
DCC0471 Ad-isec
Novel Potent Mutant p53 Rescuing Agent
More description
DCC0470 Adinazolam Mesylate
Antidepressant and anxiolytic agent, binding to peripheral-type benzodiazepine receptors that interact allosterically with GABA receptors as an agonist to produce inhibitory effects
More description
DCC0469 Aderbasib
Novel sheddase inhibitor, inhibiting the ADAM (A Disintegrin And Metalloprotease) family of multifunctional membrane-bound proteins with potential antineoplastic activity
More description
DCC0468 Adep-2b
Novel inhibitor of ClpXP complexes, causing extremely rapid dissociation of ClpXP complexes, preventing ClpX rebinding following spontaneous dissociation
More description
DCC0467 Adasgc
Novel Hsp40-Hsp70 chaperone complex inhibitor, inhibiting the Hsp40-stimulated ATPase activity of the Hsp70 chaperone, with a K i of ~10 μM
More description
DCC0465 Adamantylmethamphetamine Hcl
Potential antidepressant and anti-Parkinson agent
More description
DCC0464 Adamantylamphetamine Hydrochloride
Potential antidepressant and anti-Parkinson agent
More description
DCC0463 Ad-227
Novel potent inhibitor of the MDM2-p53 interaction
More description
DCC0462 Ad-10942-8
Novel selective USP8 inhibitor (USP8 IC50 2.1 μM; USP7 >50μM)
More description
DCC0461 Acy-1083
Novel selective HDAC6 inhibitor, showing 260-fold selectivity towards HDAC6 vs other HDACs
More description
DCC0460 Activator-3
Novel potent activator of pan-AMPK, enhancing AMPK phosphorylation by upstream kinase LKB1 and protecting AMPK complex against dephosphorylation by PP2C
More description
DCC0459 Acp-1n
Novel Inhibitor of BRD4-Driven Nucleoporin NUP210 Expression, Attenuating Colorectal Cancer Growth
More description
DCC0458 Achn975
Novel potent and selective LpxC inhibitor
More description
DCC0457 Acetophenazine Dimaleate
Antipsychotic, targeting the dopamine D2 receptor
More description
DCC0456 Acetobixan
Novel Inhibitor of Cellulose Synthesis
More description
DCC0455 Acetaminosalol
Analgesic, antipyretic, and anti-inflammatory agent
More description
DCC0454 Ac-devd-cho
Selective Caspase-3 inhibitor
More description
DCC0453 Acdala
Highly photodurable and blue-laser excitable fluorescent amino acid. acting as a highly fluorescent probe after being incorporated into specific positions of various antibodies, receptors, and enzymes
More description
DCC0452 Acc2-in-2e
Novel Acetyl-CoA Carboxylase 2 (ACC2) Selective Inhibitor, Improving Whole-Body Insulin Resistance and Hyperglycemia in Diabetic Mice through Target-Dependent Pathways
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X